id	keyword
dpc-5196	relapse
dpc-5196	patients
dpc-5196	treatment
dpc-5196	omalizumab
dpc-5196	weeks
dpc-5196	discontinuation
dpc-5196	months
dpc-5196	urticaria
dpc-5196	study